Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

about

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

Item

http://www.wikidata.org/entity/Q55283343

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

@en

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

@nl

type

Item

label

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

@en

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

@nl

prefLabel

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

@en

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

@nl

P1476

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer

@en

P2093

Agnieszka Sompolska-Rzechuła

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

Adipose tissue, obesity and adipokines: role in cancer promotion

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia.

Disruption of hypoxia-inducible factor 1 in adipocytes improves insulin sensitivity and decreases adiposity in high-fat diet-fed mice

Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis.

Oxidative stress and reactive oxygen species.

Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism.

Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.

P304

8576179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/8576179

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Ewa Pius-Sadowska

A Chudecka-Głaz

Janusz Menkiszak

Aneta Cymbaluk-Płoska

Bogusław Machaliński

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29516012

http://www.w3.org/2001/XMLSchema#string

P932

5817356

http://www.w3.org/2001/XMLSchema#string